SI-BONE, Inc. (SIBN) News
Track canonical SquawkNews coverage tagged to SIBN, SI-BONE, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 10 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
SI-BONE, Inc. (SIBN) Wins FDA 510(k) for iFuse Granite Onyx
SI-BONE received FDA 510(k) clearance for the iFuse Granite Onyx system, its first compromised-bone product for use outside the pelvis, targeting screw loosening at spinal fusion UIV/LIV.Material DetailsContext by AI Ana
REGULATION | Sep 28, 2026, 08:11 PM UTC
L
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis
FDA Breakthrough Device Designated (BDD) platform engineered for durable fixation in low density boneSANTA CLARA, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. NASDAQ:SIBN, the global leader in developing proc
REGULATION | Sep 28, 2026, 08:11 PM UTC
M
SI-BONE gets FDA 510(k) clearance for iFuse Granite Onyx
SI-BONE said the FDA cleared iFuse Granite Onyx under 510(k).
REGULATION | Sep 28, 2026, 08:09 PM UTC
M
Russian seaborne oil product exports rise 16.4% in August
Russia’s seaborne oil product exports rose 16.4% month-on-month in August to 4.57 million metric tons, according to industry sources and Reuters calculations.
ENERGY | Sep 17, 2026, 02:01 PM UTC
L
SI-BONE Enters Fourth Amendment To Lease On Sept 11, 2026 - SEC Filing
SI-BONE, Inc. NASDAQ:SIBN
REGULATION | Sep 11, 2026, 08:27 PM UTC
L
SI-BONE to present at Morgan Stanley Global Healthcare Conference Sep 14, 2026
SI-BONE (SIBN) said it will present at the Morgan Stanley 24th Global Healthcare Conference on September 14, 2026.
EQUITY | Aug 31, 2026, 08:09 PM UTC
L
SI-BONE Raises FY2026 Sales Guidance from $230.000M-$233.000M to $231.000M-$233.000M vs $231.775M Est
SI-BONE (NASDAQ: SIBN ) raises FY2026 sales outlook from $230.000 million-$233.000 million to $231.000 million-$233.000 million vs $231.775 million estimate.
EARNINGS | Aug 03, 2026, 08:25 PM UTC
L
SIBN - SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance
SIBN - SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance
EARNINGS | Aug 03, 2026, 08:09 PM UTC
L
SIBN Initiated Buy W/$24.00 PT at UBS
SIBN Initiated Buy W/$24.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
Top Initiations: ATEC BDX BLCO EW SGHT SIBN STE ZBH: BUY @ UBS COO GKOS GMED IART RXST TFX TMDX: NEUTRAL @ UBS INSP STAA: SELL @ UBS BNTC: O
Top Initiations: ATEC BDX BLCO EW SGHT SIBN STE ZBH: BUY @ UBS COO GKOS GMED IART RXST TFX TMDX: NEUTRAL @ UBS INSP STAA: SELL @ UBS BNTC: OUTPERFORM @ Wedbush CRWD: BUY @ Loop FTH: OUTPERFORM @ Opp HRB: EQUAL WEIGHT @ S
EQUITY | Jul 28, 2026, 11:11 AM UTC